Minerva Neurosciences, Inc (NERV) is a publicly traded Healthcare sector company. As of May 21, 2026, NERV trades at $4.67 with a market cap of $220.83M and a P/E ratio of -0.14. NERV moved +15.71% today. Year to date, NERV is +21.20%; over the trailing twelve months it is +264.49%. Its 52-week range spans $1.15 to $12.46. Analyst consensus is buy with an average price target of $10.50. Rallies surfaces NERV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Minerva Neurosciences, Inc (NERV) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. NERV moved +15.71% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $4.67 |
| Market Cap | $220.83M |
| P/E Ratio | -0.14 |
| EPS | $-34.67 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.46 |
| 52-Week Low | $1.15 |
| Volume | 39 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-293.42M |
| Gross Margin | 0.00% |
2 analysts cover NERV: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $10.50.